noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Karyopharm Therapeutics Inc.

A Phase I/II study of Selinexor (SEL) with Sorafenib in Patients with[...]
Karyopharm Therapeutics Inc.

Selinexor Efficacy and Safety are Independent of Renal Function in[...]
Karyopharm Therapeutics Inc.

Survival Among Patients with Relapsed/Refractory (R/R) Diffuse Large[...]

Healthcare

Karyopharm Therapeutics Inc.

01/15/2019 | Press release | Archived content

Promising activity of selinexor in the treatment of a patient with refractory diffuse large B-cell lymphoma and central nervous system involvement

Sharing and Personal Tools

Please select the service you want to use: